Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

ENOV Relative to the S&P 500

ENOV Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Enovis Corporation (NYSE:ENOV) seasonal charts above shows that a Buy Date of October 30 and a Sell Date of February 15 has resulted in a geometric average return of 7.2% above the benchmark rate of the S&P 500 Total Return Index over the past 16 years. This seasonal timeframe has shown positive results compared to the benchmark in 12 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 16 years by an average of 14.75% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Enovis Corp is a medical technology company focused on developing clinically differentiated solutions that generate measurable?patient outcomes and transform workflows by manufacturing and distributing high-quality medical devices with a broad?use for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company conducts its operations through two operating segments: Prevention & Recovery (P&R) and Reconstructive (Recon). It generates the majority of revenue from the Prevention & Recovery segment.

To download ENOV seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: ENOV